Advisory Board Co. (ABCO) is in the Business Services Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• The Advisory Board Company Q4 2008 Earnings Call Transcript

  The Advisory Board Company Q4 2008 Earnings Call Transcript

  Earnings calls 2008-05-08

  Tags: call transcript, earnings, seeking alpha, financial accounting, finance, advisory board co.

• Zacks Earnings and Margins Strategy highlights: Advisory Board Co., AAR Corp., Champion Enterprises, and Western Sierra Bancorp

  CHICAGO -- Earnings are the single most important metric for a company. Combine that with a healthy Net Profit Margin and you find a screen that has generated a cumulative return of +425% since January 2001. During the first half of 2005, this screen continued its winning ways with a...

  Research articles 2005-11-10

  Tags: aar corp., advisory board co., earnings, strategy

• Zacks Recent Price Strength Strategy Highlights: The Advisory Board Company, DXP Enterprises, LKQ Corporation, and Premiere Global Services, Inc

  CHICAGO -- This stock picking strategy looks for companies trading in the upper range of their 52-week highs along with other attractive fundamental attributes. This strategy proves that the "trend is your friend" with an average annual return of +48.1% over the last four years compared to only +1.1% for...

  Research articles 2005-05-13

  Tags: advisory board co., stock, strategy

• Zacks Recent Price Strength Strategy Highlights: The Advisory Board Company, Astec Industries, and IXYS Corporation

  CHICAGO -- This stock picking strategy looks for companies trading in the upper range of their 52-week highs along with other attractive fundamental attributes. This strategy proves that the "trend is your friend" with an average annual return of +48.1% over the last 4 years compared to only +1.1% for...

  Research articles 2005-04-05

  Tags: advisory board co., stock, strategy

• The Advisory Board Company Teams with MedeFinance as Technology Partner for New Revenue Cycle Performance Program

  Business Editors/Health/Medical Writers

  Research articles 2004-05-17

  Tags: advisory board co., performance, team

Additional Resources

• Boveran Diagnostics, Inc. Chairman Featured in CEOCast.com Interview; Discusses Company Plans and Its Cancer Detection Technology

  OXFORD, Miss., Aug. 26 /PRNewswire-FirstCall/ -- Boveran Diagnostics, Inc. (BULLETIN BOARD: BOVD) today announced its Chairman was interviewed by CEOCast.com. Mr. Welch discusses the company's cancer detection technology, the recent appointment of Nobel Prize winner Mary Mullis to its Advisory Board, and the company's operational...

  Articles 2008-08-26

• BellwetherReport.com Analyst Report on WFMI, ONNN, SRVY and ABCO

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

  Articles 2008-08-06

• The Advisory Board Company Reports Fiscal Year 2009 First Quarter Results

  Company Reports Quarterly Revenue of $57.2 million, Earnings per Diluted Share of $0.36 and Contract Value of $232.3 million; Announces New Program Launch WASHINGTON, Aug. 5 /PRNewswire-FirstCall/ -- The Advisory Board Company today announced financial results for the first quarter of its fiscal year ending March...

  Articles 2008-08-05

• The Advisory Board Company Schedules First Quarter Investor Conference Call for August 5, 2008

  WASHINGTON, July 23 /PRNewswire-FirstCall/ -- The Advisory Board Company announced today that it will hold an investor conference call hosted by Frank J. Williams, Chairman and Chief Executive Officer, Robert W. Musslewhite, Executive Vice President, and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company's financial results...

  Articles 2008-07-23

• Agios Pharmaceuticals Closes $33 Million Series A Funding

  Company Founded by Pioneers in Emerging Field of Cancer Metabolism CAMBRIDGE, Mass. -- Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel drugs that target key metabolic pathways to fundamentally disrupt cancer cells' ability to grow and survive, today announced that it...

  Articles 2008-07-07

• China Direct, Inc. Creates Board of Advisors, Names Lilia Clemente as Advisory Board Chairman

  DEERFIELD BEACH, Fla., June 26 /PRNewswire-FirstCall/ -- China Direct, Inc. , a U.S. company that owns controlling stakes in a diversified portfolio of Chinese entities and assists Chinese businesses in accessing the U.S. capital markets, has formed an advisory board to assist management and the board...

  Articles 2008-06-26

• McKesson Reinvents Revenue Management for Health Systems

  New Category of Enterprise Revenue Management Dramatically Improves the Economics of Care ATLANTA -- When it comes to finances, most healthcare organizations are operating under "code red," with an average of 80% of payments uncollected at any given time1. In addition to struggling with complex...

  Articles 2008-06-17

• /FIRST AND FINAL ADD - TO256 - Harry Winston Diamond Corporation/

  Consolidated Statements of Cash Flows expressed in thousands of United States dollars unaudited ...

  Articles 2008-06-04

• The Advisory Board Company Reports Fiscal Year 2008 Fourth Quarter Results

  Company Reports Revenue of $57.9 Million and Member Renewal Rate of 90%; Increases Share Repurchase Program by $100MM; Announces Executive Promotions, Acquisition and Launch of New Research Program WASHINGTON, May 8 /PRNewswire-FirstCall/ -- The Advisory Board Company today announced financial results for the fourth quarter of...

  Articles 2008-05-08

• Wall Street News Alert: Breaking News Alert - OCOL! May 6, 2008

  Wall Street News Alert's "stocks to watch" thismorning are: Oncolin Therapeutics (OTCBB: OCOL), Discovery Laboratories,Inc. (NASDAQ: DSCO), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). There is more important news coming from Oncolin Therapeutics (OTCBB: OCOL), and the company should have investors monitoring the stock thismorning. Yesterday after...

  Articles 2008-05-06

• Wall Street News Alert Issues Special Alert on OCOL! May 6, 2008

  Wall Street News Alert's "stocks to watch" thismorning are: Oncolin Therapeutics (OTCBB: OCOL), Vanda Pharmaceuticals Inc.(NASDAQ: VNDA), Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM), GileadSciences, Inc. (NASDAQ: GILD). There is more important news coming from Oncolin Therapeutics (OTCBB: OCOL), and the company should have investors monitoring the stock thismorning. Yesterday after the...

  Articles 2008-05-06

• Oncolin Therapeutics Announces That Dr. Randall K. Johnson Has Agreed to Join Its Scientific Advisory Board

  HOUSTON -- Oncolin Therapeutics, Inc., (OTCBB:OCOL) is pleased to announce that Dr Randall K. Johnson has agreed to join the Scientific Advisory Board of the company joining a growing number of illustrious oncologists and cancer drug developers. Dr Johnson began his career as section Head of the Experimental Chemotherapy at...

  Articles 2008-05-05

• Honda plans to ban online contract sales - maybe; Automaker will await outcome of dealer's legal challenge.(News)(Brief article)

  Byline: Kathy Jackson Urged on by its national dealer council, American Honda had decided to prohibit dealers from selling Honda-backed extended service contracts online - starting Tuesday, April 1. But the company hadn't counted on a small Rhode Island dealer...

  Articles 2008-04-07

• ONA Energy Welcomes Two New Members to its Advisory Board.

  VANCOUVER, BRITISH COLUMBIA, Apr 4, 2008 Marketwire via COMTEX -- ONA Energy Inc. ("the Company") (CNQ:OEIX)(FRANKFURT:O3X) is pleased to announce that it has added two additional members to its Advisory Board. The Company would like to welcome Jean-Pierre De Montigny and Nikolas Perrault. Mr. De Montigny...

  Articles 2008-04-04

• IDERA REPORTS 4TH QTR NET LOSS OF $4.5 MILLION.(Financial report)

  Idera Pharmaceuticals, Inc., Cambridge, Mass., (Nasdaq: IDRA) today reported financial results for the fourth quarter and full year ended December 31, 2007. During 2007 we made substantial progress in advancing our drug candidate pipeline and expanding the potential applications of...

  Articles 2008-04-01